Correlation Between Kalvista Pharmaceuticals and Zai Lab

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Zai Lab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Zai Lab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Zai Lab, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Zai Lab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Zai Lab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Zai Lab.

Diversification Opportunities for Kalvista Pharmaceuticals and Zai Lab

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Kalvista and Zai is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Zai Lab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zai Lab and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Zai Lab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zai Lab has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Zai Lab go up and down completely randomly.

Pair Corralation between Kalvista Pharmaceuticals and Zai Lab

Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 1.15 times less return on investment than Zai Lab. In addition to that, Kalvista Pharmaceuticals is 1.1 times more volatile than Zai Lab. It trades about 0.29 of its total potential returns per unit of risk. Zai Lab is currently generating about 0.36 per unit of volatility. If you would invest  2,684  in Zai Lab on November 27, 2024 and sell it today you would earn a total of  611.00  from holding Zai Lab or generate 22.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy95.24%
ValuesDaily Returns

Kalvista Pharmaceuticals  vs.  Zai Lab

 Performance 
       Timeline  
Kalvista Pharmaceuticals 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Kalvista Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Kalvista Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Zai Lab 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Zai Lab are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Zai Lab sustained solid returns over the last few months and may actually be approaching a breakup point.

Kalvista Pharmaceuticals and Zai Lab Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kalvista Pharmaceuticals and Zai Lab

The main advantage of trading using opposite Kalvista Pharmaceuticals and Zai Lab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Zai Lab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zai Lab will offset losses from the drop in Zai Lab's long position.
The idea behind Kalvista Pharmaceuticals and Zai Lab pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Managers
Screen money managers from public funds and ETFs managed around the world
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences